ΔFosB enhances the rewarding effects of cocaine while reducing the pro-depressive effects of the kappa-opioid receptor agonist U50488

Biol Psychiatry. 2012 Jan 1;71(1):44-50. doi: 10.1016/j.biopsych.2011.08.011. Epub 2011 Sep 29.

Abstract

Background: Elevated expression of the transcription factor ΔFosB accompanies repeated exposure to drugs of abuse, particularly in brain areas associated with reward and motivation (e.g., nucleus accumbens). The persistent effects of ΔFosB on target genes might play an important role in the development and expression of behavioral adaptations that characterize addiction. This study examines how ΔFosB influences the responsiveness of the brain reward system to rewarding and aversive drugs.

Methods: We used the intracranial self-stimulation paradigm to assess the effects of cocaine in transgenic mice with inducible overexpression of ΔFosB in striatal regions (including nucleus accumbens and dorsal striatum). Mice implanted with lateral hypothalamic stimulating electrodes were trained with the "rate-frequency" procedure for intracranial self-stimulation to determine the frequency at which stimulation becomes rewarding (threshold).

Results: A dose-effect analysis of cocaine effects revealed that mice overexpressing ΔFosB show increased sensitivity to the rewarding (threshold-lowering) effects of the drug, compared with littermate control subjects. Interestingly, mice overexpressing ΔFosB were also less sensitive to the pro-depressive (threshold-elevating) effects of U50488, a kappa-opioid agonist known to induce dysphoria and stress-like effects in rodents.

Conclusions: These data suggest that induction of ΔFosB in striatal regions has two important behavioral consequences-increased sensitivity to drug reward, and reduced sensitivity to aversion-producing a complex phenotype that shows signs of vulnerability to addiction as well as resilience to stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer / administration & dosage*
  • Anesthetics, Local / administration & dosage*
  • Animals
  • Biophysics
  • Cocaine / administration & dosage*
  • Conditioning, Operant / drug effects
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / genetics
  • Hypothalamic Area, Lateral / drug effects
  • Hypothalamic Area, Lateral / physiology
  • Male
  • Medial Forebrain Bundle / physiology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Phosphopyruvate Hydratase / genetics
  • Phosphopyruvate Hydratase / metabolism
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism*
  • Receptors, Opioid, kappa / agonists*
  • Reward*
  • Self Stimulation

Substances

  • Anesthetics, Local
  • Fosb protein, mouse
  • Proto-Oncogene Proteins c-fos
  • Receptors, Opioid, kappa
  • kappa(1) opioid receptor
  • 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
  • Phosphopyruvate Hydratase
  • Cocaine